Not available in AL, AR, CA, NV, LA, MS & DC
What are the practical implications for treating diabetes in light of recent evidence
8.4 Pediatric Use The safety and effectiveness of SAXENDA as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management have been established in pediatric patients aged 12 years and older with body weight above 60 kg and an initial BMI corresponding to 30 kg/m2 or greater for adults (obese) by international cut-offs
Diabetologia 66 (10), 18201831
Response timing depends on starting dose, escalation schedule, metabolic baseline, and individual GLP-1 receptor sensitivityfactors that vary significantly between individuals
Potential muscle preservation